Clostridium difficile: Back in Hospitals and Meaning Business

Clostridium difficile: Back in Hospitals and Meaning Business

0:00

Lance Peterson Lance Peterson, Evanston Northwestern Healthcare, Illinois The bacterium clostridium difficile that can cause diarrhoea in hospital patients is making a resurgence. It’s potential

Lance Peterson

Lance Peterson

Lance Peterson, Evanston Northwestern Healthcare, IllinoisThe bacterium clostridium difficile that can cause diarrhoea in hospital patients is making a resurgence. It’s potentially very aggressive, and it’s not so easy to detect any more. But a new real-time polymerase chain reaction (PCR) test reported at the ICAAC conference looking for genes involved with production of the C. difficile product: toxin B promises to help fight the problem.

Click here for all the interviews from ICAAC 2005

Tags

C.-difficileclostridiumpatient

Related Episodes

Routine Angioplasty Recommended After Thrombolysis

Routine Angioplasty Recommended After Thrombolysis

Warren Cantor Tony Gershlick REFERENCE: Abstract 2404-3 SCAI-ACCi2 Late-Breaking Clinical Trials II: Acute Myocardial Infarction Warren Cantor, University of Toronto COMMENT: Tony Gershlick, Leicester

Debate: Adjuvant Chemotherapy Should Be Standard in Stage I Non-Small Cell Lung Cancer

Debate: Adjuvant Chemotherapy Should Be Standard in Stage I Non-Small Cell Lung Cancer

Giorgio Scagliotti Robert Pirker GIORGIO SCAGLIOTTI, University of Turin ROBERT PIRKER, Medical University of Vienna A heated debate took place at the European Congress on Lung Cancer in Turin between

Front Line Therapy in Non-Small Cell Lung Cancer

Front Line Therapy in Non-Small Cell Lung Cancer

Nick Thatcher NICK THATCHER, Christie Hospital, Manchester There is a proven benefit in survival if you give your patients cis-platinum based chemotherapy after resection for non-small cell lung cance